Tag
The article discusses the ethical dilemma of balancing AI development for potential medical breakthroughs, like cancer cures, against concerns about slowing progress. It poses questions about when caution might start causing more harm than good.
Biotech startup Vivodyne claims current AI models lack sufficient human tissue data for effective drug discovery and has developed robotic labs called HIVE to generate this data, aiming to improve preclinical testing for diseases like cancer.
Reed Jobs, son of Steve Jobs, manages a $1B+ VC firm called Yosemite that invests in cancer research and biotech, including AI drug discovery and gene editing, with the goal of making cancer non-lethal.
NASA astronaut Chris Williams concludes his eight-month ISS mission, contributing to cancer treatment research, semiconductor crystal growth, and Earth observation experiments.
A new peer-reviewed study published in Gut Microbes found that a single intravenous dose of the frog-derived gut bacterium Ewingella americana completely eradicated tumors in 100% of mice with colorectal cancer, outperforming chemotherapy and immune checkpoint blockade while showing no toxicity.
New University of Calgary research shows that knocking out a single gene makes colon cancer cells visible to the immune system, and when combined with immunotherapy, leads to 100% tumor eradication in mouse models, offering a potential new approach for treating colorectal cancer.
Big progress against two of the most deadly cancers reported from randomized trials, as highlighted by Eric Topol during the ASCO conference.
A clinical trial found that the daily pill daraxonrasib doubles survival time for patients with pancreatic cancer, offering a significant breakthrough in treatment with fewer side effects compared to chemotherapy.
A new study proposes viewing tumors as organized ecosystems rather than random mutations, using AI to analyze spatial organization, immune localization, and signaling environments in oncology.
Orakl Oncology is leveraging the DINOv2 model to integrate machine learning with experimental insights, aiming to accelerate cancer treatment discovery and drug development.
AI tools such as AlphaFold help Ugandan researchers conduct local cancer genetic research, narrowing breast cancer vaccine candidate targets from 15,000 to 15. This significantly lowers the research threshold and demonstrates the potential for democratizing science.